A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients - Kim, Hyung Joon; Kim, Ju Hyun; Yeon, Jong Eun; Seo, Yeon Seok; Jang, Jeong Won; Cho, Yong Kyun; Jang, Byoung Kuk; Han, Byung Hoon; Lee, Changhyeong; Lee, Joon Hyeok; Yoon, Jung-Hwan; Kim, Kang Mo; et al. (Journal of Korean medical science, 2022)
Keywords: Adult; Antiviral Agents - therapeutic use; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hepatitis B, Chronic - drug therapy; Humans; Male; Middle Aged; Original; Orotic Acid - therapeutic use; Republic of Korea; Tenofovir - therapeutic use; Treatment Outcome; 의학일반; Republic of Korea; Tenofovir; Efficacy; Safety; Hepatitis B Virus; Hepatitis B, Chronic